CWM
KERX

Cornerstone Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Cornerstone Wealth Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,693
Closed -$213K – 1307
2018
Q3 		$213K Buy
1,693
+903
+114% +$3.26K ﹤0.01% 1171
2018
Q2 		$213K Buy
+790
New +$3.85K ﹤0.01% 1303

Cornerstone Wealth Management's KERX Position: Q4 2018 in Review

Cornerstone Wealth Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,693 shares — an estimated $213K sold.

Cornerstone Wealth Management first reported a position in KERX in Q2 2018 and held it in 2 quarters. The position peaked at $213K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Cornerstone Wealth Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Cornerstone Wealth Management sold 1,693 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $213K.
  • Cornerstone Wealth Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
  • Cornerstone Wealth Management's Keryx Biopharmaceuticals Inc position peaked at $213K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Cornerstone Wealth Management's 13F filing for Q4 2018, filed 13 Feb 2019.